Ezetimibe
CAS: 163222-33-1
Ref. 3D-FE23215
| 25mg | 136.00 € | ||
| 50mg | 152.00 € | ||
| 100mg | 218.00 € | ||
| 250mg | 366.00 € | ||
| 500mg | 496.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Product Information
Name:
Ezetimibe
Synonyms:
- (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
- Sch 58235
- (-)-Sch 58235
- (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone, Sch-58235
- (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
- 1-(4-Fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)azetidin-2-one
- 1-(4-Fluorophenyl)-3-[3-(4-Fluorophenyl)-3-Hydroxy-Propyl]-4-(4-Hydroxyphenyl)-Azetidin-2-One
- 1-(4-Flurophenyl)-(3R)-3-(4-flurophenyl)-(3S)-hydroxypropyl-(4S)-(4-hydroxyphenyl)-2-azetidinone
- 2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-
- 2-Azetidinone, 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, [3R-[3α(S*),4β]]-
- See more synonyms
- Ezedoc
- Ezentia
- EzetimibeC24H21F2N03
- Ezetimide
- Ezetrol
- Ezitimibe&Int
- Zetia
- Ezitimibe∬ EzetimibeC24H21F2N03
Description:
Inhibitor of cholesterol transporter NPC1L1
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
409.43 g/mol
Formula:
C24H21F2NO3
Purity:
Min. 95%
Color/Form:
White Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-FE23215 Ezetimibe
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
